Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination.

ABSTRACT: SARS-CoV-2 mRNA booster vaccines provide protection from severe disease, eliciting strong immunity that is further boosted by previous infection. However, it is unclear whether these immune responses are affected by the interval between infection and vaccination. Over a two-month period, we evaluated antibody and B-cell responses to a third dose mRNA vaccine in 66 individuals with different infection histories. Uninfected and post-boost but not previously infected individuals mounted robust ancestral and variant spike-binding and neutralizing antibodies, and memory B cells. Spike-specific B-cell responses from recent infection were elevated at pre-boost but comparatively less so at 60 days post-boost compared to uninfected individuals, and these differences were linked to baseline frequenc

SUBMITTER: Buckner CM 

PROVIDER: S-EPMC9460969 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature